Predict sight-threatening complications from diabetes
RETMARKER AI TECHNOLOGY MONITORS AND PREVENTS RETINAL DISEASES' COMPLICATIONS
Consistent tracking of microaneurysms allows risk prediction
In Retinal diseases, activity is a key concept!
It is fundamental to monitor lesions and how they evolve over time.
Microaneurysms (MA) are the initial lesion in DR.
Monotoring them allows to understand when new MAs appear (formation) and their disappearance.
The MA turnover combines such information and is, according with several studies, correlated to the risk of developing sight-threatening complications.
Retmarker DR computes all this indicators from color fundus photographs allowing the prediction of the individual risk.
Those involved in research and clinical trials know how hard it is to identify the best individuals for the study population.
The Biomarker helps to identify the risk of DR complications on each individual.